SG11202107289TA - Artificial tears - Google Patents

Artificial tears

Info

Publication number
SG11202107289TA
SG11202107289TA SG11202107289TA SG11202107289TA SG11202107289TA SG 11202107289T A SG11202107289T A SG 11202107289TA SG 11202107289T A SG11202107289T A SG 11202107289TA SG 11202107289T A SG11202107289T A SG 11202107289TA SG 11202107289T A SG11202107289T A SG 11202107289TA
Authority
SG
Singapore
Prior art keywords
artificial tears
tears
artificial
Prior art date
Application number
SG11202107289TA
Inventor
Laurence Fitzhenry
Sangeeta Kumari
Original Assignee
Waterford Institute Of Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Waterford Institute Of Tech filed Critical Waterford Institute Of Tech
Publication of SG11202107289TA publication Critical patent/SG11202107289TA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51Nanocapsules; Nanoparticles
    • A61K9/5107Excipients; Inactive ingredients
    • A61K9/5123Organic compounds, e.g. fats, sugars
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/04Artificial tears; Irrigation solutions
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG11202107289TA 2018-11-05 2019-11-05 Artificial tears SG11202107289TA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1818043.0A GB201818043D0 (en) 2018-11-05 2018-11-05 Artifical Tears
PCT/IB2019/059479 WO2020095192A1 (en) 2018-11-05 2019-11-05 Artificial tears

Publications (1)

Publication Number Publication Date
SG11202107289TA true SG11202107289TA (en) 2021-08-30

Family

ID=64655626

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202107289TA SG11202107289TA (en) 2018-11-05 2019-11-05 Artificial tears

Country Status (8)

Country Link
US (1) US20210386679A1 (en)
EP (1) EP3876913A1 (en)
JP (1) JP2022506684A (en)
KR (1) KR20210088623A (en)
CN (1) CN113784707A (en)
GB (1) GB201818043D0 (en)
SG (1) SG11202107289TA (en)
WO (1) WO2020095192A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022026796A1 (en) * 2020-07-31 2022-02-03 Altaire Pharmaceuticals, Inc. Ophthalmic compositions for delivering meibum-like materials

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007517893A (en) * 2004-01-10 2007-07-05 バイオリピッド インコーポレイテッド Lipid composition and method of using the lipid composition
ES2384060B1 (en) * 2010-03-24 2013-09-23 Lipotec S.A. LIPID NANOPARTICLES CAPSULES.
CN102048696B (en) * 2011-01-13 2013-08-07 南昌大学 Preparation method of lipid nanoparticles
KR101445265B1 (en) * 2012-09-18 2014-09-30 포항공과대학교 산학협력단 Hyaluronic acid-nucleic acid conjugate and composition for nucleic acid delivery containing the same
NZ725028A (en) * 2014-05-01 2019-01-25 Integral Biosystems Llc Membrane-adherent self-assembled systems for treatment of ocular disorders
CN103989660A (en) * 2014-06-05 2014-08-20 武汉武药科技有限公司 Azithromycin-containing slow-released eye drops and preparation method thereof
CN104337851B (en) * 2014-10-28 2017-10-17 华东理工大学 The preparation method of brucea fruit oil nano structured lipid carrier and its freeze-dried powder
JP2017095386A (en) * 2015-11-20 2017-06-01 参天製薬株式会社 Release control composition
GB201721832D0 (en) * 2017-12-22 2018-02-07 Waterford Institute Of Tech Ocular drug delivery
GB201721840D0 (en) * 2017-12-22 2018-02-07 Waterford Institute Of Tech Microemulsion for opthalmic drug delivery

Also Published As

Publication number Publication date
CN113784707A (en) 2021-12-10
GB201818043D0 (en) 2018-12-19
US20210386679A1 (en) 2021-12-16
KR20210088623A (en) 2021-07-14
WO2020095192A1 (en) 2020-05-14
EP3876913A1 (en) 2021-09-15
JP2022506684A (en) 2022-01-17

Similar Documents

Publication Publication Date Title
CA185383S (en) Casque
CA185382S (en) Casque
CA185384S (en) Casque
CA185385S (en) Casque
DK3554057T3 (en) Audioheadsetsystem
DK3613739T3 (en) Integrin-antagonister
GB201804070D0 (en) Stents
CA184989S (en) Uroflowmeter
EP3773331C0 (en) Implant
HUE055578T2 (en) Temporo-mandibular prosthesis
DK3633783T3 (en) Universal-powerbank
CA184994S (en) Uroflowmeter
PL3653183T3 (en) Ocular insert
IL280267A (en) Patch
GB2570018B (en) Prosthesis
PL3700475T3 (en) Stent
SG11202007131UA (en) Patch
GB201811833D0 (en) Patch
GB2565152B (en) Intraocular lens
SG11202107289TA (en) Artificial tears
GB2588316B (en) Earplugs
DK3570498T3 (en) Adaptivt hvac-styresystem
GB201906753D0 (en) Prosthesis
EP3593806A4 (en) Thermogelling artificial tears
DK3578923T3 (en) Navigationssystem